Search

everythinglearnresearchcommunity

for

Search:↓

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Nanofat injections can significantly improve hair growth in men with hair loss for up to a year.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Minoxidil lowers blood pressure and causes hair growth, with some side effects.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Exosomes from stem cells may help rejuvenate skin and regrow hair, but more research is needed.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

A patient with Wilson's disease showed hair-pulling behavior as an initial symptom.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.